Ligand Pharmaceuticals (LGND) News
NASDAQ: LGNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
286.85-0.09 (-0.03%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LGND news summary
We found 8 recent headlines mentioning Ligand Pharmaceuticals (LGND): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. For price context, LGND is down 0.03% at $286.85. The most recent story, "Ligand Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Oct 29, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Ligand Pharmaceuticals headlines
- Ligand Reports Third Quarter 2026 Financial ResultsLigand Pharmaceuticals Incorporated reported financial results for the three and nine months ended September 30, 2026. Total revenues and income for the third quarter of 2026 were $78.7 million,…Nasdaq
- Ligand Pharmaceuticals Non-GAAP EPS of $2.67 beats by $0.34, revenue of $78.75M beats by $1.52MSeeking Alpha
- Ligand Reports Third Quarter 2026 Financial ResultsLigand Reports Third Quarter 2026 Financial ResultsGlobeNewswire
- Ligand Pharmaceuticals Q3 2026 Earnings PreviewSeeking Alpha
- Ligand to Participate in November Investor ConferencesLigand to Participate in November Investor ConferencesGlobeNewswire
- Ligand to Host Investor Day on December 8, 2026Ligand to Host Investor Day on December 8, 2026GlobeNewswire
- Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026GlobeNewswire
- Stocks Supported by Strength in Chipmakers and AI-Infrastructure StocksThe S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.50%. September E-mini S&P futures…NasdaqMSTR, AMAT, GOOGL, SNDK